Clinical Trial Protocol Information

Clinical trial protocol information for active or completed studies are available below.

If you are a patient, physician, or researcher seeking more information about Takeda’s active or completed clinical trials in the Japanese language please click here.


All Clinical Trial Protocol Information

Search

C26004

A Phase 1/2 Trial of MLN0264 in Previously Treated Asian Patients With Advanced Gastrointestinal (GI) Carcinoma (Phase 1) or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma...
www.clinicaltrials.gov/ct2/show/NCT02391038

Febuxostat XR-1010

A Phase 1, Open-Label, Single Center, Single-Dose, Randomized, 4-Way Crossover Study to Assess the Effect of an Antacid on the Bioavailability of Febuxostat After Oral Administration of a 80 mg Febuxo...
www.clinicaltrials.gov/ct2/show/NCT02382640

MT203/CPH-001

A Randomized, Single-center, Double-Blind, Placebo-Controlled Phase 1 Study to Evaluate Safety and Pharmacokinetics of Single Subcutaneous Injection of MT203 in Healthy Adult Japanese and Caucasian Ma...
www.clinicaltrials.gov/ct2/show/NCT02354599

M1-1188_202

A 24-Week Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Finding Study to Evaluate the Efficacy and Safety of 3 Doses of Namilumab (20 mg, 80 mg and 150 mg) in Combination With Methotrexat...
www.clinicaltrials.gov/ct2/show/NCT02379091

Febuxostat XR-1009

A Phase 1, Open-Label, Single-Center, Randomized, 3-Way Crossover Study to Assess the Effect of Food on the Bioavailability of a Single Oral Dose of 80 mg Febuxostat Extended-Release Formulation and t...
www.clinicaltrials.gov/ct2/show/NCT02374164

C34002

An Open-Label, Phase 1b/2 Study Investigating Recommended Phase 2 Dose, Safety, Tolerability, and Preliminary Efficacy of TAK-659 in Adult Patients With Relapsed or Refractory Acute Myelogenous Leukem...
www.clinicaltrials.gov/ct2/show/NCT02323113

MLN3126_103

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential-Cohort, Ascending Multiple Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 i...
www.clinicaltrials.gov/ct2/show/NCT02209506

C26003

A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
www.clinicaltrials.gov/ct2/show/NCT02202785

SYR-472

A phase II dose-ranging study of SYR-472   http://www.clinicaltrials.jp/user/cteDetail.jsp[2011/06/30 14:55:11] JapicCTI-No. JapicCTI-090899 A phase ...
www.takeda.com/siteassets/system/what-we-do/research-and-development-rd-in-takeda/plotocol-infomation/pager-5/10_syr-472_information_for_registration_-japiccti_en.pdf

AD-4833MET

A study to investigate the optimum dosage regimen of metformin in combination with pioglitazone in patients with type 2 diabetes mellitus Protocol Summary Name of Sponsor Company: Takeda Pharmace...
www.takeda.com/siteassets/system/what-we-do/research-and-development-rd-in-takeda/plotocol-infomation/pager-10/ad-4833met-.pdf

TCV-116(2)

Efficacy and safety of candesartan cilexetil compared to ramipril on ambulatory systolic blood pressure assessed in treated non-controlled, or non-treated hypertensive patients April 03, 2007 PROTOCO...
www.takeda.com/siteassets/system/what-we-do/research-and-development-rd-in-takeda/plotocol-infomation/pager-10/f-can-541_pr_en.pdf

TCV-116(3)

Efficacy and safety of candesartan cilexetil combined with 12.5 mg of HCTZ compared to valsartan combined with 12.5 mg of HCTZ on self-measured systolic blood pressure in hypertensive patients not con...
www.takeda.com/siteassets/system/what-we-do/research-and-development-rd-in-takeda/plotocol-infomation/pager-10/f-can-542_pr_en.pdf

TAK-390MR / CCT-001

Investigation of the efficacy/safety and clinical dose of TAK-390MR for Erosive Esophagitis - A Phase II/III, Stratified-Randomized, Double-Blind, Parallel-Group, Multicenter Study on Efficacy and Saf...
www.takeda.com/siteassets/system/what-we-do/research-and-development-rd-in-takeda/plotocol-infomation/pager-8/japiccti-080539.pdf

ATL-962 / CCT-002

A phase III, multicenter, randomized, stratified, placebo-controlled, double-blind, parallel group study to investigate the efficacy and safety of ATL-962 in obese patients with type II diabetes and d...
www.takeda.com/siteassets/system/what-we-do/research-and-development-rd-in-takeda/plotocol-infomation/pager-8/japiccti-080658.pdf

TAK-536

Phase 3 study of TAK-536 (confirmatory trial) BeraglJapal Pharmaaesrgaal Ildmrmargml Aelrer Alglgaal Trgal Ildmrmargml hrrp:--www.alglgaalrrgals.hp-sser-areBeragl_e.hsp[0011-03-07 10:31:21] ?Basic i...
www.takeda.com/siteassets/system/what-we-do/research-and-development-rd-in-takeda/plotocol-infomation/pager-7/japiccti-090762.pdf

ATL-962(2)

A phase III study of ATL-962 in subject with obesity DetailJapan Pharmaceutical Information Center Clinical Trial Information http://www.clinicaltrials.jp/user/cteDetail_e.jsp[2014/02/25 14:16:56] ?...
www.takeda.com/siteassets/system/what-we-do/research-and-development-rd-in-takeda/plotocol-infomation/pager-5/japiccti-090858.pdf